Details for 2011770622

Up to date per 02.04.2026

Actions

Title / Product Name

NEUE KRISTALLINE FORMEN DES NATRIUMSALZES VON (4- {4- [5- (6 - TRIFLUORMETHYL - PYRIDIN- 3 - YLAMINO) - PYRIDIN- 2 -YL] -PHENYL} - CYCLOHEXYL) -ESSIGSÄURE

Status

Deleted

Protection Type

European Patent

(AT-) Application Number

2011770622

EP Publication Number

2625172

E-Number

851568

Language

PCT Number

US11054841

Publication Date

14.08.2013 A

07.12.2016 B1

Registration Date

07.12.2016

AT Publication Date

15.12.2016

Application Date

05.10.2011

Registration Number

Priorities

07.10.2010

390888 P

IPC

C07D 213/72 20060101AFI20160517BHEP

Maximum Duration of Protection

05.10.2031

Owner

Novartis AGLichtstrasse 35 4056 BaselCH

Representative

Schwarz & Partner Patentanwälte OGWipplingerstraße 301010 WienAT

Inventor

SUTTON, Paul, AllenNovartis Pharmaceuticals Corporation One Health Plaza East Hanover New Jersey 07936-1080US

GIRGIS, Michael, J.Novartis Pharmaceuticals Corporation One Health Plaza East Hanover New Jersey 07936-1080US

LIANG, JessicaNovartis Pharmaceuticals Corporation One Health Plaza East Hanover New Jersey 07936-1080US

PRASHAD, MahavirNovartis Pharmaceuticals Corporation One Health Plaza East Hanover New Jersey 07936-1080US

VILLHAUER, Edwin, BernardNovartis Pharmaceuticals Corporation One Health Plaza East Hanover New Jersey 07936-1080US